The observation that myeloma-reactive PD-1+ CD4+ and CD8+ T cells secrete both IFN-γ and IL-10 suggests these cells may be at the crossroads of an immune switch from effector to tolerogenic [24]. This evidence concerns the gene IL10 and plasma cell myeloma.